Sandostatin LAR is a Octreotide product supplied as long-acting release injection. The photographed packaging identifies the presentation as 30 mg.
| Brand | Sandostatin LAR |
|---|---|
| Active ingredient | Octreotide |
| Strength / presentation | 30 mg |
| Dosage form | Long-acting release injection |
| Pack shown | Injection pack |
| Company shown on pack | Novartis |
Contact Zeemedix to confirm current availability and the pack supplied. Use and administration should follow the product leaflet and the directions of your healthcare professional.
